News
An Australian life science company that is the exclusive wholesale distributor for the EAORON branded skin care range to pharmacies, supermarkets and specialist retailers in Australia and New Zealand and owns, produces, designs and distributes its own range of consumer health products under the EZZ brand.
The Company has two distinct and synergistic business models: a wholesale distribution model for the EAORON branded products in the skin care segment; and an integrated model including development, production and distribution for the EZZ branded products in the consumer health segment. Synergy is created by selling the EZZ branded products to established distribution channels previously developed from selling the EAORON branded products
EZZ Life Science formulate, produce, market and distribute health supplements under the brand of EZZ, with a focus on products with significant demand from the market by consumers.
KEY PEOPLE
RELATED STOCKHEAD STORIES
Health & Biotech
EZZ forges partnership with high-end travel retailer amid resurgence of Chinese Visitors to Australia
Health & Biotech
EZZ Life Science is selling its products on Chemist Warehouse’s new online marketplace
Health & Biotech
A global footprint: EZZ is expanding into Europe’s $38.2 billion dietary supplement market
Health & Biotech
These are the ASX stocks Morgans thinks can push the health and wellness agenda
Health & Biotech
EZZ’s launches new China e-commerce partnership with HIC
News
In Case You Missed It: Construction materials player beats resources for top spot
Health & Biotech
EZZ outperforms guidance with 147% revenue growth in FY23
Health & Biotech
Obesity drug Wegovy takes the world by storm. Could that impact ASX stocks like Holista Colltech?
News
In Case You Missed It: Imminent copper production, and comms company could meet full year guidance
Health & Biotech
ASX Health Stocks: Pro Medicus nabs $24m, 7-year deal with world renowned cancer hospital
Health & Biotech
EZZ in top shape delivering strong Q4 FY23 results including 21% rise in cash receipts
News
Good Morning Vietnam: These ASX companies are doing a roaring trade in the ‘Tiger Cub economy’
Health & Biotech
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends
Health & Biotech
EZZ looks to Vietnam for growth after returning from Vietbaby exhibition
News
CLOSING BELL: Mega gold merger outweighs bankers’ ex-div dive, leaving the ASX up 0.1%
Health & Biotech
EZZ enters new distribution partnership to extend foothold in China projected to boost revenue by $16 million annually
Health & Biotech